80 FR 39786 - Center for Scientific Review; Notice of Closed Meeting
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health Federal Register Volume 80, Issue 132 (July 10, 2015)
National Institutes of Health
Federal Register Volume 80, Issue 132 (July 10, 2015)
| Page Range | 39786-39787 | |
| FR Document | 2015-16841 |
[Federal Register Volume 80, Number 132 (Friday, July 10, 2015)] [Notices] [Pages 39786-39787] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2015-16841] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Topics in Steroids Regulation and Disease. Date: July 9, 2015. Time: 1:30 p.m. to 2:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Elaine Sierra-Rivera, Ph.D., Scientific Review Officer, Genes, Genomes, and Genetics IRG, Center for Scientific Review, National Institutes of Health, 6701 [[Page 39787]] Rockledge Drive, Room 2200, MSC 7890, Bethesda, MD 20892, 301 435- 2514, [email protected]. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: July 2, 2015. Carolyn Baum, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2015-16841 Filed 7-9-15; 8:45 am] BILLING CODE 4140-01-P
![39786 Federal Register / Vol. 80, No. 132 / Friday, July 10, 2015 / Notices
remedies within SSA and HHS have III. How To Use the Notice OCPM Division IV: Part D Coverage
been exhausted. Determinations
Sections 1869, 1155, 1876(c)(5)(B), This notice lists the OCPM chapters
and subjects published during the Chapter 3, Procedural Screening. This
1852(g)(5), and 1860D–4(h) of the Act new chapter describes the review
are implemented through the quarter covered by the notice so the
reader may determine whether any are process for new requests for hearing on
regulations at 42 CFR part 405 subparts Medicare Part D reconsiderations issued
I and J; part 417, subpart Q; part 422, of particular interest. We expect this
notice to be used in concert with future by an Independent Review Entity. The
subpart M; part 423, subparts M and U; review process helps ensure requests are
and part 478, subpart B. As noted above, published notices. The OCPM can be
accessed at http://www.hhs.gov/omha/ complete and jurisdictional
OMHA administers the nationwide requirements are met.
Administrative Law Judge hearing OMHA_Case_Processing_Manual/
program in accordance with these index.html. OCPM Division V: SSA Determinations
statutes and applicable regulations. As IV. OCPM Releases for March Through Chapter 3, Procedural Screening. This
part of that effort, OMHA is establishing June 2015 new chapter describes the review
a manual, the OMHA Case Processing process for new requests for hearing on
Manual (OCPM). Through the OCPM, The OCPM is used by OMHA reconsiderations of Medicare eligibility
the OMHA Chief Administrative Law adjudicators and staff to administer the and entitlement, Part B late enrollment
Judge establishes the day-to-day OMHA program. It offers day-to-day penalties, and Part B and Part D
procedures for carrying out adjudicative operating instructions, policies, and IRMAAs issued by SSA. The review
functions, in accordance with procedures based on statutes and process helps ensure requests are
applicable statutes, regulations and regulations, and OMHA directives. complete and jurisdictional
OMHA directives. The OCPM provides The following is a list and description requirements are met.
direction for processing appeals at the of new OCPM provisions and the Dated: June 30, 2015.
OMHA level of adjudication for subject matter. For future quarterly Nancy J. Griswold,
Medicare Part A and B claims; Part C notices, we will list only the specific Chief Administrative Law Judge, Office of
organization determinations; Part D updates to the list of manual provisions Medicare Hearings and Appeals.
coverage determinations; and SSA that have occurred in the covered 3- [FR Doc. 2015–16824 Filed 7–9–15; 8:45 am]
eligibility and entitlement, Part B late month period. This information is BILLING CODE 4152–01–P
enrollment penalty, and IRMAA available on our Web site at http://www.
determinations. hhs.gov/omha/OMHA_Case_Processing_
Section 1871(c) of the Act requires Manual/index.html. DEPARTMENT OF HEALTH AND
that we publish a list of all Medicare HUMAN SERVICES
manual instructions, interpretive rules, OCPM Division I: General Matters
statements of policy, and guidelines of Chapter 1, Manual Overview, National Institutes of Health
general applicability not issued as Definitions, Governance. This new
regulations at least every 3 months in Center for Scientific Review; Notice of
chapter provides a general overview of Closed Meeting
the Federal Register. the OCPM, including the purpose of the
II. Format for the Quarterly Issuance manual, how it is organized and used, Pursuant to section 10(d) of the
Notices a list of acronyms and abbreviations Federal Advisory Committee Act, as
used in the manual, and how manual amended (5 U.S.C. App.), notice is
This quarterly notice announces the provisions will be updated. hereby given of the following meeting.
publication of the initial OCPM The meeting will be closed to the
chapters. A hyperlink to the available OCPM Division II: Part A/B Claim public in accordance with the
chapters on the OMHA Web site is Determinations provisions set forth in sections
provided below. The OMHA Web site 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
contains the most current, up-to-date Chapter 3, Procedural Screening. This
new chapter describes the review as amended. The grant applications and
chapters and revisions to chapters, and the discussions could disclose
will be available earlier than we publish process for new requests for hearing on
Medicare Part A and Part B confidential trade secrets or commercial
our quarterly notice. We believe the property such as patentable material,
OMHA Web site list provides more reconsiderations issued by Qualified
Independent Contractors (QICs) and and personal information concerning
timely access to the current OCPM individuals associated with the grant
chapters for those involved in the Quality Improvement Organizations
(QIOs), and escalations of requests for applications, the disclosure of which
Medicare claim, organization and would constitute a clearly unwarranted
coverage determination and entitlement reconsideration by a QIC. The review
process helps ensure requests are invasion of personal privacy.
appeals processes. We also believe the
complete and jurisdictional Name of Committee: Center for Scientific
Web site offers the public a more Review Special Emphasis Panel; Member
convenient tool for real time access to requirements are met.
Conflict: Topics in Steroids Regulation and
current OCPM provisions. In addition, OCPM Division III: Part C Organization Disease.
OMHA has a listserv to which the Determinations Date: July 9, 2015.
public can subscribe to receive Time: 1:30 p.m. to 2:30 p.m.
mstockstill on DSK4VPTVN1PROD with NOTICES
immediate notification of any updates to Chapter 3, Procedural Screening. This Agenda: To review and evaluate grant
the OMHA Web site. This listserv new chapter describes the review applications.
avoids the need to check the OMHA process for new requests for hearing on Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
Web site, as update notifications are Medicare Part C reconsiderations issued (Telephone Conference Call).
sent to subscribers as they occur. If by an Independent Review Entity and Contact Person: Elaine Sierra-Rivera, Ph.D.,
accessing the OMHA Web site proves to QIOs. The review process helps ensure Scientific Review Officer, Genes, Genomes,
be difficult, the contact person listed requests are complete and jurisdictional and Genetics IRG, Center for Scientific
above can provide the information. requirements are met. Review, National Institutes of Health, 6701
VerDate Sep<11>2014 19:51 Jul 09, 2015 Jkt 235001 PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 E:\FR\FM\10JYN1.SGM 10JYN1](https://thefederalregister.org/doc/80_FR_39918/page/1.svg)
![Federal Register / Vol. 80, No. 132 / Friday, July 10, 2015 / Notices 39787
Rockledge Drive, Room 2200, MSC 7890, Dated: July 7, 2015. DEPARTMENT OF HEALTH AND
Bethesda, MD 20892, 301 435–2514, David Clary, HUMAN SERVICES
riverase@csr.nih.gov.
This notice is being published less than 15 Program Analyst, Office of Federal Advisory
Committee Policy. National Institutes of Health
days prior to the meeting due to the timing
limitations imposed by the review and [FR Doc. 2015–16937 Filed 7–9–15; 8:45 am]
Office of the Director; Notice of Charter
funding cycle. BILLING CODE 4140–01–P Renewal
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine; In accordance with Title 41 of the
93.333, Clinical Research, 93.306, 93.333, DEPARTMENT OF HEALTH AND U.S. Code of Federal Regulations,
93.337, 93.393–93.396, 93.837–93.844, HUMAN SERVICES section 102–3.65(a), notice is hereby
93.846–93.878, 93.892, 93.893, National given that the Charter for the
Institutes of Health, HHS) Recombinant DNA Advisory Committee,
National Institutes of Health
Dated: July 2, 2015. National Institutes of Health, was
Carolyn Baum, National Institute of Diabetes and renewed for an additional two-year
Program Analyst, Office of Federal Advisory Digestive and Kidney Diseases; Notice period on June 30, 2015.
Committee Policy. of Closed Meeting It is determined that the Recombinant
[FR Doc. 2015–16841 Filed 7–9–15; 8:45 am]
DNA Advisory Committee, National
Pursuant to section 10(d) of the Institutes of Health, is in the public
BILLING CODE 4140–01–P
Federal Advisory Committee Act, as interest in connection with the
amended (5 U.S.C. App.), notice is performance of duties imposed on the
DEPARTMENT OF HEALTH AND hereby given of the following meeting. National Institutes of Health by law, and
HUMAN SERVICES that these duties can best be performed
The meeting will be closed to the through the advice and counsel of this
public in accordance with the group.
National Institutes of Health
provisions set forth in sections Inquiries may be directed to Jennifer
National Institute of Allergy and 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Spaeth, Director, Office of Federal
Infectious Diseases: Notice of Closed as amended. The grant applications and Advisory Committee Policy, Office of
Meeting the discussions could disclose the Director, National Institutes of
confidential trade secrets or commercial Health, 6701 Democracy Boulevard,
Pursuant to section 10(d) of the property such as patentable material, Suite 1000, Bethesda, Maryland 20892
Federal Advisory Committee Act, as and personal information concerning (Mail code 4875). Telephone (301) 496–
amended (5 U.S.C. App.), notice is individuals associated with the grant 2123, or spaethj@od.nih.gov.
hereby given of the following meeting. applications, the disclosure of which Dated: July 6, 2015.
The meeting will be closed to the would constitute a clearly unwarranted Carolyn A. Baum,
public in accordance with the invasion of personal privacy. Program Analyst, Office of Federal Advisory
provisions set forth in sections Committee Policy.
Name of Committee: National Institute of
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., [FR Doc. 2015–16839 Filed 7–9–15; 8:45 am]
Diabetes and Digestive and Kidney Diseases
as amended. The grant applications and
Special Emphasis Panel; Diabetes Ancillary BILLING CODE 4140–01–P
the discussions could disclose Studies.
confidential trade secrets or commercial Date: July 29, 2015.
property such as patentable material, Time: 3:00 p.m. to 4:00 p.m. DEPARTMENT OF HEALTH AND
and personal information concerning Agenda: To review and evaluate grant HUMAN SERVICES
individuals associated with the grant applications.
applications, the disclosure of which Place: National Institutes of Health, Two National Institutes of Health
would constitute a clearly unwarranted Democracy Plaza, 6707 Democracy
invasion of personal privacy. Government-Owned Inventions;
Boulevard, Bethesda, MD 20892 (Telephone
Availability for Licensing
Name of Committee: National Institute of Conference Call).
Allergy and Infectious Diseases Special Contact Person: Carol J. Goter-Robinson, AGENCY: National Institutes of Health,
Emphasis Panel; Opportunities for Ph.D., Scientific Review Officer, Review HHS.
Collaborative Research at the NIH Clinical Branch, DEA, NIDDK, National Institutes of ACTION: Notice.
Center (U01). Health, Room 748, 6707 Democracy
Date: August 14, 2015. Boulevard, Bethesda, MD 20892–5452, (301) SUMMARY: The inventions listed below
Time: 11:00 a.m. to 6:00 p.m. are owned by an agency of the U.S.
594–7791, goterrobinsonc@
Agenda: To review and evaluate grant
applications. extra.niddk.nih.gov. Government and are available for
Place: National Institutes of Health, (Catalogue of Federal Domestic Assistance licensing in the U.S. in accordance with
Conference Room 3F100, 5601 Fishers Lane, Program Nos. 93.847, Diabetes, 35 U.S.C. 209 and 37 CFR part 404 to
Rockville, MD 20852, (Telephone Conference Endocrinology and Metabolic Research; achieve expeditious commercialization
Call). 93.848, Digestive Diseases and Nutrition of results of federally-funded research
Contact Person: Brenda Lange-Gustafson, Research; 93.849, Kidney Diseases, Urology and development. Foreign patent
Ph.D., Scientific Review Officer, NIAID/NIH/ and Hematology Research, National Institutes applications are filed on selected
DHHS, Scientific Review Program, 5601 inventions to extend market coverage
mstockstill on DSK4VPTVN1PROD with NOTICES
of Health, HHS)
Fishers Lane, Room 3G13 Rockville, MD for companies and may also be available
20852, 240–669–5047, bgustafson@ Dated: July 6, 2015.
niaid.nih.gov.
for licensing.
David Clary,
FOR FURTHER INFORMATION CONTACT:
(Catalogue of Federal Domestic Assistance Program Analyst, Office of Federal Advisory
Program Nos. 93.855, Allergy, Immunology, Licensing information and copies of the
Committee Policy. U.S. patent applications listed below
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases [FR Doc. 2015–16840 Filed 7–9–15; 8:45 am] may be obtained by writing to the
Research, National Institutes of Health, HHS) BILLING CODE 4140–01–P indicated licensing contact at the Office
VerDate Sep<11>2014 21:07 Jul 09, 2015 Jkt 235001 PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 E:\FR\FM\10JYN1.SGM 10JYN1](https://thefederalregister.org/doc/80_FR_39918/page/2.svg)
Document Created: 2018-02-23 09:15:53
Document Modified: 2018-02-23 09:15:53
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Dates | July 9, 2015. | |
| FR Citation | 80 FR 39786 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR